Cargando…
SYK expression level distinguishes control from BRCA1-mutated lymphocytes
BACKGROUND: About 5%–10% of breast cancer and 10%–15% of ovarian cancer are hereditary. BRCA1 and BRCA2 are the most common germline mutations found in both inherited breast and ovarian cancers. Once these mutations are identified and classified, a course of action to reduce the risk of developing e...
Autores principales: | Zahavi, Tamar, Sonnenblick, Amir, Shimshon, Yael, Kadouri, Luna, Peretz, Tamar, Salmon, Asher Y, Salmon-Divon, Mali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875411/ https://www.ncbi.nlm.nih.gov/pubmed/29618939 http://dx.doi.org/10.2147/CMAR.S156359 |
Ejemplares similares
-
Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model
por: Zahavi, Tamar, et al.
Publicado: (2015) -
Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
por: Anabel Sinberger, Liat, et al.
Publicado: (2023) -
Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment
por: Raphael, Ari, et al.
Publicado: (2022) -
Transcriptomic Analysis of the Brucella melitensis Rev.1 Vaccine Strain in an Acidic Environment: Insights Into Virulence Attenuation
por: Salmon-Divon, Mali, et al.
Publicado: (2019) -
The Acidic Stress Response of the Intracellular Pathogen Brucella melitensis: New Insights from a Comparative, Genome-Wide Transcriptome Analysis
por: Kornspan, David, et al.
Publicado: (2020)